RxDoctor Payments Data

Hussein Warda, MD

Urogynecology and Reconstructive Pelvic Surgery · Greenwood, INNPI 1154631273

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 29.6% of the total.

$10,402in general payments, 2019–2025

Across 100 payments — averaging $104.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Axonics, Inc.$2K
  • Intuitive Surgical$2K
  • Coloplast$2K
  • Medtronic$861
  • AbbVie$117
  • plus $381 from 9 others

What the payments were for

  • Travel & lodging$5,24750%
  • Food & beverage$4,02839%
  • Education$1,12711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,402 in reported general payments places this provider in the 75th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Indiana.

See all urogynecology and reconstructive pelvic surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$109,022
Medicare patients
212
Services billed
1,044

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron56$63,069
Estradiol336$23,495
EstringEstradiol25$12,856
PremarinEstrogens, Conjugated13$5,669
Mirabegron ErMirabegron11$3,902
YuvafemEstradiol15$2,602
Tolterodine Tartrate ErTolterodine Tartrate25$1,403
Oxybutynin Chloride ErOxybutynin Chloride21$860
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst65$594
Ibuprofen30$100
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$67
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$55
Cephalexin16$48
Metronidazole29$46

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Greenwood

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →